AP3031A - Avian influenza viruses, compositions, formulations, and methods - Google Patents

Avian influenza viruses, compositions, formulations, and methods

Info

Publication number
AP3031A
AP3031A AP2008004625A AP2008004625A AP3031A AP 3031 A AP3031 A AP 3031A AP 2008004625 A AP2008004625 A AP 2008004625A AP 2008004625 A AP2008004625 A AP 2008004625A AP 3031 A AP3031 A AP 3031A
Authority
AP
ARIPO
Prior art keywords
formulations
compositions
methods
avian influenza
influenza viruses
Prior art date
Application number
AP2008004625A
Other languages
English (en)
Other versions
AP2008004625A0 (en
Inventor
Scott L Krauss
Richard J Webby
Erich Hoffmann
Original Assignee
Zoetis W Llc
St Jude Childrens Res Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis W Llc, St Jude Childrens Res Hospital filed Critical Zoetis W Llc
Publication of AP2008004625A0 publication Critical patent/AP2008004625A0/xx
Application granted granted Critical
Publication of AP3031A publication Critical patent/AP3031A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AP2008004625A 2006-04-21 2007-04-23 Avian influenza viruses, compositions, formulations, and methods AP3031A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79405406P 2006-04-21 2006-04-21
US11/737,104 US9072701B2 (en) 2006-04-21 2007-04-18 Avian influenza viruses, vaccines, compositions, formulations, and methods
PCT/US2007/067205 WO2007124479A2 (en) 2006-04-21 2007-04-23 Avian influenza viruses, vaccines, compositions, formulations, and methods

Publications (2)

Publication Number Publication Date
AP2008004625A0 AP2008004625A0 (en) 2008-10-31
AP3031A true AP3031A (en) 2014-11-30

Family

ID=38625803

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004625A AP3031A (en) 2006-04-21 2007-04-23 Avian influenza viruses, compositions, formulations, and methods

Country Status (5)

Country Link
US (1) US9072701B2 (zh)
CN (1) CN101448520B (zh)
AP (1) AP3031A (zh)
HK (1) HK1129570A1 (zh)
WO (1) WO2007124479A2 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1846028A4 (en) * 2005-01-05 2010-06-30 Philadelphia Health & Educatio ADMINISTRATION VEHICLES, BIOACTIVE SUBSTANCES AND VIRAL VACCINES
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US8080645B2 (en) * 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
CA2697373C (en) 2007-08-27 2019-05-21 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
ES2552858T3 (es) 2007-10-01 2015-12-02 Longhorn Vaccines And Diagnostics, Llc Recogida de muestras biológicas y sistema de transporte y métodos de uso
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
JP2012519484A (ja) 2009-03-06 2012-08-30 マウント・シナイ・スクール・オヴ・メディシン マイクロｒｎａ応答要素を含む弱毒化生インフルエンザウイルスワクチン
WO2011108999A1 (en) * 2010-03-05 2011-09-09 Agricultural Research Development Agency (Public Organization) Vaccines and vaccine compositions, and methods for the manufacture thereof
CN104203272A (zh) 2012-01-26 2014-12-10 长角牛疫苗和诊断有限责任公司 复合抗原序列及疫苗
US9981034B2 (en) * 2015-04-17 2018-05-29 South Dakota Board Of Regents Compositions and methods for vaccination against influenza A virus
US9976136B2 (en) 2015-05-14 2018-05-22 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples
KR101857863B1 (ko) 2016-06-17 2018-05-14 건국대학교 산학협력단 신규한 조류 인플루엔자 h5n9 재조합 바이러스 및 이를 포함하는 백신 조성물
CN108103084B (zh) * 2017-11-21 2020-06-26 浙江迪福润丝生物科技有限公司 区分免疫和感染动物h5亚型禽流感疫苗株及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050054846A1 (en) * 2003-09-04 2005-03-10 Webster Robert Gordon Method for generating influenza viruses and vaccines
US20050158342A1 (en) * 2003-12-23 2005-07-21 Medimmune, Inc. Multi plasmid system for the production of influenza virus
US20060204976A1 (en) * 2004-10-07 2006-09-14 Wyeth Multivalent avian influenza vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923176D0 (en) * 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
PT1317559E (pt) 2000-04-28 2009-02-12 St Jude Childrens Res Hospital Sistema de transfecção de adn para a produção de vírus infecciosos de arn de cadeia negativa
EP1980268A2 (en) 2002-04-12 2008-10-15 Ilaria Capua Vaccination methods against avian influenza virus
CN1678345A (zh) 2002-04-26 2005-10-05 米迪缪尼疫苗股份有限公司 制备流感病毒的多质粒系统
WO2007126810A2 (en) * 2006-03-31 2007-11-08 Warf - Wisconsin Alumni Research Foundation High titer recombinant influenza viruses for vaccines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050054846A1 (en) * 2003-09-04 2005-03-10 Webster Robert Gordon Method for generating influenza viruses and vaccines
US20050158342A1 (en) * 2003-12-23 2005-07-21 Medimmune, Inc. Multi plasmid system for the production of influenza virus
US20060204976A1 (en) * 2004-10-07 2006-09-14 Wyeth Multivalent avian influenza vaccines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [Online] GOVORKOVA ET AL. Database accession no. (AAW80718) *
DATABASE GENBANK [Online] WEBBY ET AL. Database accession no. (AAO62036) *

Also Published As

Publication number Publication date
AP2008004625A0 (en) 2008-10-31
US9072701B2 (en) 2015-07-07
WO2007124479A3 (en) 2007-12-27
WO2007124479A2 (en) 2007-11-01
US20080118531A1 (en) 2008-05-22
CN101448520A (zh) 2009-06-03
HK1129570A1 (zh) 2009-12-04
CN101448520B (zh) 2013-12-25

Similar Documents

Publication Publication Date Title
AP3031A (en) Avian influenza viruses, compositions, formulations, and methods
HRP20190378T1 (hr) Prolijekovi tetrahidrokanabinola, pripravci koji sadržavaju prolijekove tetrahidrokanabinola i postupci za njihovu uporabu
EP1984405A4 (en) INFLUENZA ANTIGENS, VACCINE COMPOSITIONS AND ASSOCIATED METHODS
IL193392A0 (en) Influenza antibodies, compositions, and related methods
HK1201720A1 (zh) 冷凍溫度穩定流感疫苗成分
IL196024A0 (en) Influenza vaccine
IL186710A (en) Influenza A virus is isolated from dogs, a drug and vaccine that include it and its use
HK1223968A1 (zh) 狂犬病病毒組合物和方法
HK1112846A1 (en) Canine influenza virus and related compositions and methods of use
PL2422810T3 (pl) Szczepionka przeciw grypie
IL207372A0 (en) Phenylpyrrole derivatives, compositions comprising the same and uses thereof
WO2008147496A3 (en) Neuraminidase-deficient live influenza vaccines
HK1215037A1 (zh) 流感抑制組合物和方法
ZA200809056B (en) Influenza virus vaccine
EP2097103A4 (en) VACCINE FORMULATIONS AGAINST INFLUENZA
EP2094279A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZA
ZA200900062B (en) Influenza vaccine
FR2873386B1 (fr) Composition vaccinale contre le rhodococcus equi
ZA200803031B (en) Canine influenza virus and related compositions and methods of use
GB0619090D0 (en) Influenza vaccine
GB0623865D0 (en) Influenza vaccine
GB0625453D0 (en) Influenza vaccine
GB0618195D0 (en) Influenza vaccine
IL191977A0 (en) Improved influenza vaccine